Author Affiliation: Department of Clinical Pharmacy and Health Policy, University of California, San Francisco.
This review is an update of an earlier review of studies examining the association of pharmaceutical industry sponsorship of drug studies and research outcomes.1 The review was converted to a Cochrane Methodology Review, updated to double the number of included studies, and the scope was expanded to include device studies. The review also examines whether industry-sponsored studies have different risks of bias compared with non–industry-sponsored studies.2 Two of the authors of the review were supported by grants for their work on the review; Octavian A. Busuioc, from the Canadian Institutes of Health Research, and Andreas Lundh, from the Julie von Mullens Foundation and Kontorchef Gerhard Bronsteds Travel Grant, Denmark. The full review is available at http://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000033.pub2/pdf.
Bero L. Industry Sponsorship and Research OutcomeA Cochrane Review. JAMA Intern Med. 2013;173(7):580-581. doi:10.1001/jamainternmed.2013.4190